RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
IX Biopharma Stock

IX Biopharma ROCE 2024

IX Biopharma ROCE

-1.62

Ticker

42C.SI

ISIN

SG1BD9000009

In 2024, IX Biopharma's return on capital employed (ROCE) was -1.62, a -2,687.26% increase from the 0.06 ROCE in the previous year.

IX Biopharma Aktienanalyse

What does IX Biopharma do?

IX Biopharma Ltd is a leading biopharmaceutical company based in Singapore. The company was founded in 2007 by Dr. Jan-Olof Heldin, a globally recognized biotech entrepreneur. The history of IX Biopharma dates back to the late 90s, when Dr. Heldin began working on a new method of drug delivery called "Oral Transmucosal Technology" (OTM). This technology allows for the development of drugs that can quickly and specifically penetrate the body, with a very high bioavailability. Today, IX Biopharma has a strong presence in the market for novel OTM-based drugs. The company operates in three different business areas: human medicine products, animal health, and life sciences. IX Biopharma's human medicine products are specialized in the treatment of pain and inflammation. The company has already launched a product - a fast-acting spray for pain relief. This new technology allows the medication to quickly enter the body and take effect, providing patients with rapid pain relief. IX Biopharma is currently working on additional products based on OTM technology to provide suitable solutions for other medical conditions as well. In the animal health sector, IX Biopharma offers veterinary products tailored to the needs of pets and livestock. The company collaborates closely with veterinarians and livestock experts to develop innovative therapies and treatment methods customized for specific animal needs. In the field of life sciences, IX Biopharma engages in a wide range of activities and services. These include the development of diagnostic products, conducting clinical trials, identifying biomarkers, and developing immunotherapies. Overall, IX Biopharma is an innovative biopharmaceutical company specializing in the development of drugs based on new technologies. The company is constantly striving to find innovative solutions to improve the health of humans and animals. With a dedicated team of scientists and researchers, as well as a strong presence in Asia and Europe, IX Biopharma is a pioneer in the new world of OTM-based drug development. IX Biopharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling IX Biopharma's Return on Capital Employed (ROCE)

IX Biopharma's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing IX Biopharma's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

IX Biopharma's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in IX Biopharma’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about IX Biopharma stock

What is the ROCE (Return on Capital Employed) of IX Biopharma this year?

The ROCE of IX Biopharma is -1.62 undefined this year.

How has the ROCE (Return on Capital Employed) of IX Biopharma developed compared to the previous year?

The ROCE of IX Biopharma has increased by -2,687.26% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of IX Biopharma?

A high Return on Capital Employed (ROCE) indicates that IX Biopharma has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of IX Biopharma?

A low ROCE (Return on Capital Employed) can indicate that IX Biopharma has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from IX Biopharma impact the company?

An increase in the ROCE of IX Biopharma can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of IX Biopharma affect the company?

A decrease in ROCE of IX Biopharma can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of IX Biopharma?

Some factors that can affect IX Biopharma's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of IX Biopharma so important for investors?

The ROCE of IX Biopharma is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can IX Biopharma take to improve the ROCE?

To improve the ROCE, IX Biopharma can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does IX Biopharma pay?

Over the past 12 months, IX Biopharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IX Biopharma is expected to pay a dividend of 0 SGD.

What is the dividend yield of IX Biopharma?

The current dividend yield of IX Biopharma is .

When does IX Biopharma pay dividends?

IX Biopharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of IX Biopharma?

IX Biopharma paid dividends every year for the past 0 years.

What is the dividend of IX Biopharma?

For the upcoming 12 months, dividends amounting to 0 SGD are expected. This corresponds to a dividend yield of 0 %.

In which sector is IX Biopharma located?

IX Biopharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von IX Biopharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of IX Biopharma from 10/3/2024 amounting to 0 SGD, you needed to have the stock in your portfolio before the ex-date on 10/3/2024.

When did IX Biopharma pay the last dividend?

The last dividend was paid out on 10/3/2024.

What was the dividend of IX Biopharma in the year 2023?

In the year 2023, IX Biopharma distributed 0 SGD as dividends.

In which currency does IX Biopharma pay out the dividend?

The dividends of IX Biopharma are distributed in SGD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von IX Biopharma

Our stock analysis for IX Biopharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IX Biopharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.